.Francesco Bertoni, MD, Group Leader

Vice-director

Phone: +41 91 820 0367
Email: francesco -dot- bertoni -at- ior -dot- usi -dot- ch

 

Dr. Francesco Bertoni obtained a Medical Degree magna cum laude (1994) and the Medical Oncology Specialty (1998) from the State University of Milan.

During his career he has worked in Milan (Ospedale Maggiore Policlinico and “Mario Negri” Institute of Pharmacological Research), London (Institute of Child Health and The Barts and The London) and in Ticino (Servizio Oncologico Cantonale).

Since April 2003 Bertoni is the head of the Lymphoma Genomics group at IOR (IOSI Laboratory of Experimental Oncology until 2011). Since April 2007, he is the deputy director of the Institute.

Dr. Bertoni actively participates to Swiss Cancer Research Group (SAKK), in which he is vice-president of the Project Group Lymphoma and member of the Project Group New Anticancer Treatment. Since January 2009 Dr. Bertoni is the Editor-in-Chief of the Hematological Oncology journal.

Dr. Bertoni’s research topics are the development of new anti-lymphoma compounds and lymphoma genomics.

He is the author or co-author of over 190 original papers, over 50 editorials or invited reviews, 20 book sections, one edited book, several abstracts at national and international meetings, and over ten patents.

A full list of publications is available at: https://www.dropbox.com/s/4mvdfunv5kkcau6/pubs.pdf?dl=0